» Articles » PMID: 9676851

Prognostic Value and Clinicopathological Profile of Microsatellite Instability in Gastric Cancer

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 1998 Jul 24
PMID 9676851
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, microsatellite instability (MI) was investigated in 126 gastric carcinomas and correlated with clinicopathological features and prognosis; at least 5-10 microsatellite loci were analyzed. MI was identified in 56 (44.5%) of all investigated carcinomas, one locus being affected in 40 (31.7%) carcinomas, two loci being affected in 6 (4.8%) carcinomas, and more than two loci being affected in 10 (8.0%) carcinomas. MI was correlated with neither age and sex of the patients nor with depth of invasion, lymph node metastasis, tumor differentiation, or histological type according to WHO and Laurén classification. The frequency of MI was the same in early gastric carcinomas as it was in advanced gastric carcinomas, suggesting that MI arises early during the tumorigenesis of gastric cancer. No significant differences in survival could be demonstrated between patients with MI-negative and MI-positive gastric carcinomas.

Citing Articles

The role of TLRs (microbe recognition receptor) in gastric cancer: An update.

Jasim S, Abdulrazzaq S, Malathi H, Iqbal S, Sanghvi G, Yulchiev E Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40063240 DOI: 10.1007/s00210-025-03966-7.


Heterogeneity and Adjuvant Therapeutic Approaches in MSI-H/dMMR Resectable Gastric Cancer: Emerging Trends in Immunotherapy.

Wu H, Ma W, Jiang C, Li N, Xu X, Ding Y Ann Surg Oncol. 2023; 30(13):8572-8587.

PMID: 37667098 PMC: 10625937. DOI: 10.1245/s10434-023-14103-0.


Establish immune-related gene prognostic index for esophageal cancer.

Guo C, Zeng F, Liu H, Wang J, Huang X, Luo J Front Genet. 2022; 13:956915.

PMID: 36035171 PMC: 9401516. DOI: 10.3389/fgene.2022.956915.


The Roles of Immune Cells in Gastric Cancer: Anti-Cancer or Pro-Cancer?.

Sukri A, Hanafiah A, Ritza Kosai N Cancers (Basel). 2022; 14(16).

PMID: 36010915 PMC: 9406374. DOI: 10.3390/cancers14163922.


Are We Benign? What Can Wnt Signaling Pathway and Epithelial to Mesenchymal Transition Tell Us about Intracranial Meningioma Progression.

Bukovac A, Kafka A, Raguz M, Brlek P, Dragicevic K, Muller D Cancers (Basel). 2021; 13(7).

PMID: 33915799 PMC: 8037732. DOI: 10.3390/cancers13071633.